The outcome of this study suggests an increased risk of breast cancer for women with NF1 < 50 years old and the need for early and annual of radiographic screening for breast cancer in NF1 patients. However, more research is needed to determine the optimal screening program and timing. This evidence concerns the gene NF1 and breast carcinoma.